CIBC Bancorp USA »

Taysha Gene Therapies shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2025-09-30 $74k 23k 3.27

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Ishares Tr U.s. Real Es Etf (IYR)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Linde SHS (LIN)
Cognizant Technology Solutio Cl A (CTSH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for CIBC Bancorp USA

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies